GAD1 and type 1 diabetes mellitus: A study from South Africa in 2002 [13] using a newer, simpler, and more precise method for detecting autoantibodies (by radioimmunoassay) identified GAD autoantibodies in 44% of patients with T1D and 2.5% of African patients with Type 2 diabetes (T2D).